161 related articles for article (PubMed ID: 25311554)
1. Effect of extended follow-up in a specialized heart failure clinic on adherence to guideline recommended therapy: NorthStar Adherence Study.
Schou M; Gislason G; Videbaek L; Kober L; Tuxen C; Torp-Pedersen C; Hildebrandt PR; Gustafsson F;
Eur J Heart Fail; 2014 Nov; 16(11):1249-55. PubMed ID: 25311554
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study.
Luttik ML; Jaarsma T; van Geel PP; Brons M; Hillege HL; Hoes AW; de Jong R; Linssen G; Lok DJ; Berge M; van Veldhuisen DJ
Eur J Heart Fail; 2014 Nov; 16(11):1241-8. PubMed ID: 25302753
[TBL] [Abstract][Full Text] [Related]
3. Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar).
Schou M; Gustafsson F; Videbaek L; Tuxen C; Keller N; Handberg J; Sejr Knudsen A; Espersen G; Markenvard J; Egstrup K; Ulriksen H; Hildebrandt PR;
Eur Heart J; 2013 Feb; 34(6):432-42. PubMed ID: 22875412
[TBL] [Abstract][Full Text] [Related]
4. Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
Albert NM; Fonarow GC; Yancy CW; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride M; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
Am Heart J; 2010 Feb; 159(2):238-44. PubMed ID: 20152222
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
6. Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure.
Poelzl G; Altenberger J; Pacher R; Ebner CH; Wieser M; Winter A; Fruhwald F; Dornaus C; Ehmsen U; Reiter S; Steinacher R; Huelsmann M; Eder V; Boehmer A; Pilgersdorfer L; Ablasser K; Keroe D; Groebner H; Auer J; Jakl G; Hallas A; Ess M; Ulmer H;
Int J Cardiol; 2014 Jul; 175(1):83-9. PubMed ID: 24857326
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
[TBL] [Abstract][Full Text] [Related]
8. Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care.
Gjesing A; Schou M; Torp-Pedersen C; Køber L; Gustafsson F; Hildebrandt P; Videbæk L; Wiggers H; Demant M; Charlot M; Gislason GH
Eur J Heart Fail; 2013 Jun; 15(6):671-8. PubMed ID: 23397577
[TBL] [Abstract][Full Text] [Related]
9. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
Fonarow GC; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Inge PJ; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
Circulation; 2010 Aug; 122(6):585-96. PubMed ID: 20660805
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure.
Brackbill ML; Bashaw-Keaton R; Sytsma CS
Am J Manag Care; 2007 Oct; 13(10):568-70. PubMed ID: 17927461
[TBL] [Abstract][Full Text] [Related]
11. Specialized heart failure clinics versus primary care: Extended registry-based follow-up of the NorthStar trial.
Malmborg M; Assad Turky Al-Kahwa A; Kober L; Torp-Pedersen C; Butt JH; Zahir D; Tuxen CD; Poulsen MK; Madelaire C; Fosbol E; Gislason G; Hildebrandt P; Andersson C; Gustafsson F; Schou M
PLoS One; 2023; 18(6):e0286307. PubMed ID: 37289772
[TBL] [Abstract][Full Text] [Related]
12. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
[TBL] [Abstract][Full Text] [Related]
13. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
14. The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure.
Matthews JC; Johnson ML; Koelling TM
Am Heart J; 2007 Dec; 154(6):1174-83. PubMed ID: 18035092
[TBL] [Abstract][Full Text] [Related]
15. Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study).
Schou M; Gustafsson F; Videbaek L; Andersen H; Toft J; Nyvad O; Ryde H; Fog L; Jensen JC; Nielsen OW; Lind-Rasmussen S; Abdulla J; Hildebrandt PR;
Eur J Heart Fail; 2013 Jul; 15(7):818-27. PubMed ID: 23507787
[TBL] [Abstract][Full Text] [Related]
16. Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart Failure Adherence Retention Trial (HART).
Calvin JE; Shanbhag S; Avery E; Kane J; Richardson D; Powell L
Congest Heart Fail; 2012; 18(2):73-8. PubMed ID: 22432552
[TBL] [Abstract][Full Text] [Related]
17. If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment?
Dierckx R; Cleland JG; Pellicori P; Zhang J; Goode K; Putzu P; Boyalla V; Clark AL
J Telemed Telecare; 2015 Sep; 21(6):331-9. PubMed ID: 25766855
[TBL] [Abstract][Full Text] [Related]
18. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
[TBL] [Abstract][Full Text] [Related]
19. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
Circ Heart Fail; 2008 Jul; 1(2):98-106. PubMed ID: 19808279
[TBL] [Abstract][Full Text] [Related]
20. Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey.
Jotkowitz AB; Porath A; Shotan A; Mittelman M; Grossman E; Zimlichman R; Lewis BS; Caspi A; Gottlieb S; Garty M;
Isr Med Assoc J; 2006 Dec; 8(12):875-9. PubMed ID: 17214110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
